<PAGE>   1

   AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 13, 2000
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                             ---------------------

                                   FORM 10-Q

(MARK ONE)

    [X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
             EXCHANGE ACT OF 1934

             FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2000

                                       OR

    [  ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
              SECURITIES EXCHANGE ACT OF 1934

               FOR THE TRANSITION PERIOD FROM ________ TO ________

                         COMMISSION FILE NUMBER 0-22585

                          HEALTHCARE RECOVERIES, INC.
             (Exact Name of Registrant as Specified in its Charter)

<TABLE>
<S>                                            <C>
                  DELAWARE                                      61-1141758
       (State or Other Jurisdiction of                       (I.R.S. Employer
       Incorporation or Organization)                       Identification No.)

 1400 WATTERSON TOWER, LOUISVILLE, KENTUCKY                        40218
  (Address of Principal Executive Offices)                      (Zip Code)
</TABLE>

                                 (502) 454-1340
              (Registrant's Telephone Number, Including Area Code)

     Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.  YES [X]  NO [ ]

     As of November 13, 2000, 10,047,871 shares of the Registrant's Common
Stock, $0.001 par value were outstanding.

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE>   2

                          HEALTHCARE RECOVERIES, INC.

                                   FORM 10-Q
                               SEPTEMBER 30, 2000

                                     INDEX

<TABLE>
<CAPTION>
                                                              PAGE
                                                              ----
<S>                                                           <C>
PART I:  FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
  Condensed Balance Sheets as of September 30, 2000 and
     December 31, 1999......................................    1
  Condensed Statements of Income for the three and nine
     months ended September 30, 2000 and 1999...............    2
  Condensed Statements of Cash Flows for the nine months
     ended September 30, 2000 and 1999......................    3
  Notes to Condensed Financial Statements...................    4
Item 2. Management's Discussion and Analysis of Financial
  Condition and Results of Operations.......................    8
Item 3. Quantitative and Qualitative Disclosures About
  Market Risk...............................................   14
PART II:  OTHER INFORMATION
Item 1. Legal Proceedings...................................   15
Item 6. Exhibits and Reports on Form 8-K....................   18
Signatures..................................................   19
</TABLE>

     THIS FORM 10-Q AND OTHER STATEMENTS ISSUED OR MADE FROM TIME TO TIME BY
HEALTHCARE RECOVERIES, INC. OR MEMBERS OF ITS MANAGEMENT TEAM CONTAIN STATEMENTS
WHICH MAY CONSTITUTE "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE
SECURITIES ACT OF 1933 AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED BY
THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995, 15 U.S.C.A. SECTIONS 77Z-2
AND 78U-5 (SUPP. 1996). THOSE STATEMENTS INCLUDE STATEMENTS REGARDING THE
INTENT, BELIEF OR CURRENT EXPECTATIONS OF HEALTHCARE RECOVERIES, INC. AND
MEMBERS OF ITS MANAGEMENT TEAM, AS WELL AS THE ASSUMPTIONS ON WHICH SUCH
STATEMENTS ARE BASED. PROSPECTIVE INVESTORS ARE CAUTIONED THAT ANY SUCH
FORWARD-LOOKING STATEMENTS ARE NOT GUARANTEES OF FUTURE PERFORMANCE AND INVOLVE
RISKS AND UNCERTAINTIES, AND THAT ACTUAL RESULTS MAY DIFFER MATERIALLY FROM
THOSE CONTEMPLATED BY SUCH FORWARD-LOOKING STATEMENTS. IMPORTANT FACTORS
CURRENTLY KNOWN TO MANAGEMENT THAT COULD CAUSE ACTUAL RESULTS TO DIFFER
MATERIALLY FROM THOSE IN FORWARD-LOOKING STATEMENTS ARE SET FORTH IN THE SAFE
HARBOR COMPLIANCE STATEMENT FOR FORWARD-LOOKING STATEMENTS INCLUDED AS EXHIBIT
99.1 TO THIS FORM 10-Q, AND ARE HEREBY INCORPORATED HEREIN BY REFERENCE.
HEALTHCARE RECOVERIES, INC. UNDERTAKES NO OBLIGATION TO UPDATE OR REVISE
FORWARD-LOOKING STATEMENTS TO REFLECT CHANGED ASSUMPTIONS OR CIRCUMSTANCES, THE
OCCURRENCE OF UNANTICIPATED EVENTS OR CHANGES TO FUTURE OPERATING RESULTS OVER
TIME.
<PAGE>   3

                                     PART I

                             FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS (UNAUDITED)

                          HEALTHCARE RECOVERIES, INC.

                            CONDENSED BALANCE SHEETS
                                  (UNAUDITED)
                  (IN THOUSANDS, EXCEPT PER SHARE INFORMATION)

<TABLE>
<CAPTION>
                                                              SEPTEMBER 30,   DECEMBER 31,
                                                                  2000            1999
                                                              -------------   ------------
<S>                                                           <C>             <C>
                                          ASSETS
Current assets:
  Cash and cash equivalents.................................    $    718        $  1,670
  Restricted cash...........................................      19,923          26,121
  Accounts receivable, less allowance for doubtful accounts
    of $443 in 2000 and $380 in 1999........................       8,236           6,870
  Other current assets......................................       1,257           1,319
                                                                --------        --------
         Total current assets...............................      30,134          35,980
                                                                --------        --------
Property and equipment, at cost:
  Buildings and land........................................       4,001           5,482
  Furniture and fixtures....................................       3,230           3,095
  Office equipment..........................................       1,991           1,946
  Computer equipment........................................      13,320          11,253
  Leasehold improvements....................................       1,308           1,073
                                                                --------        --------
                                                                  23,850          22,849
  Accumulated depreciation and amortization.................     (12,829)        (10,002)
                                                                --------        --------
         Property and equipment, net........................      11,021          12,847
                                                                --------        --------
  Cost in excess of net assets acquired, net................      28,610          26,296
  Identifiable intangibles, net.............................       5,074           5,496
  Other assets..............................................       1,425           1,274
                                                                --------        --------
         Total assets.......................................    $ 76,264        $ 81,893
                                                                ========        ========
                           LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Trade accounts payable....................................    $  1,554        $  1,914
  Accrued expenses..........................................       5,501          12,005
  Funds due clients.........................................      11,379          13,178
  Income taxes payable......................................       1,090           1,018
                                                                --------        --------
         Total current liabilities..........................      19,524          28,115
Other liabilities...........................................       2,056           2,055
Long-term borrowings........................................      14,500          11,000
                                                                --------        --------
         Total liabilities..................................      36,080          41,170
                                                                --------        --------
Commitments and contingencies
Stockholders' equity:
  Preferred stock, $.001 par value per share; 2,000 shares
    authorized; no shares issued or outstanding.............          --              --
  Common stock, $.001 par value per share; 20,000 shares
    authorized; 10,210 and 11,209 shares issued and
    outstanding as of September 30, 2000 and December 31,
    1999, respectively......................................          12              12
  Capital in excess of par value............................      22,636          22,541
  Other.....................................................        (898)           (369)
  Treasury stock at cost; 1,333 shares at September 30, 2000
    and 305 shares at December 31, 1999.....................      (5,145)         (1,373)
  Retained earnings.........................................      23,579          19,912
                                                                --------        --------
         Total stockholders' equity.........................      40,184          40,723
                                                                --------        --------
         Total liabilities and stockholders' equity.........    $ 76,264        $ 81,893
                                                                ========        ========
</TABLE>

     The accompanying notes are an integral part of the condensed financial
                                  statements.

                                        1
<PAGE>   4

                          HEALTHCARE RECOVERIES, INC.

                         CONDENSED STATEMENTS OF INCOME
                                  (UNAUDITED)
        FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2000 AND 1999
                  (IN THOUSANDS, EXCEPT PER SHARE INFORMATION)

<TABLE>
<CAPTION>
                                                            THREE MONTHS ENDED    NINE MONTHS ENDED
                                                               SEPTEMBER 30,        SEPTEMBER 30,
                                                            -------------------   -----------------
                                                              2000       1999      2000      1999
                                                            --------   --------   -------   -------
<S>                                                         <C>        <C>        <C>       <C>
Claims revenues...........................................  $15,113    $15,247    $47,628   $44,901
Cost of services..........................................    7,322      7,986     23,430    22,973
                                                            -------    -------    -------   -------
          Gross profit....................................    7,791      7,261     24,198    21,928
Support expenses..........................................    3,951      3,856     12,906    11,547
Depreciation and amortization.............................    1,637      1,310      4,777     3,597
                                                            -------    -------    -------   -------
          Operating income................................    2,203      2,095      6,515     6,784
Interest income...........................................      300        266        847       800
Interest expense..........................................      375        263      1,004       681
Other -- Special Committee expenses.......................       --         --         90        --
                                                            -------    -------    -------   -------
          Income before income taxes......................    2,128      2,098      6,268     6,903
Provision for income taxes................................      883        871      2,601     2,865
                                                            -------    -------    -------   -------
          Net income......................................  $ 1,245    $ 1,227    $ 3,667   $ 4,038
                                                            =======    =======    =======   =======
Basic earnings per common share...........................  $  0.12    $  0.11    $  0.34   $  0.36
                                                            =======    =======    =======   =======
Diluted earnings per common share.........................  $  0.12    $  0.11    $  0.33   $  0.36
                                                            =======    =======    =======   =======
</TABLE>

     The accompanying notes are an integral part of the condensed financial
                                  statements.

                                        2
<PAGE>   5

                          HEALTHCARE RECOVERIES, INC.

                       CONDENSED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)
             FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND 1999
                                 (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                              NINE MONTHS ENDED
                                                                SEPTEMBER 30,
                                                              ------------------
                                                               2000       1999
                                                              -------   --------
<S>                                                           <C>       <C>
Cash flows from operating activities:
  Net income................................................  $ 3,667   $  4,038
  Adjustments to reconcile net income to net cash provided
     by operating activities:
     Depreciation and amortization..........................    4,777      3,597
     Deferred income taxes..................................       (3)       161
     Other..................................................       (7)       238
     Changes in operating assets and liabilities:
       Restricted cash......................................    2,010      2,337
       Accounts receivable..................................   (1,366)      (773)
       Other current assets.................................      710         85
       Other assets.........................................     (411)       (71)
       Trade accounts payable...............................     (990)        50
       Accrued expenses.....................................   (1,922)       190
       Funds due clients....................................   (1,801)    (1,897)
       Income taxes payable.................................       72     (1,089)
       Other liabilities....................................       --       (246)
                                                              -------   --------
          Net cash provided by operating activities.........    4,736      6,620
                                                              -------   --------
Cash flows from investing activities:
  Acquisitions, net of cash acquired........................   (3,881)   (44,599)
  Disposals of property and equipment.......................    1,409         --
  Purchases of property and equipment.......................   (2,506)    (3,060)
                                                              -------   --------
          Net cash used in investing activities.............   (4,978)   (47,659)
                                                              -------   --------
Cash flows from financing activities:
  Line of credit proceeds...................................    7,700     14,300
  Line of credit repayments.................................   (4,200)    (2,000)
  Repurchase of common stock................................   (3,772)    (1,373)
  Issuance of common stock..................................       91         98
  Other.....................................................     (529)        --
                                                              -------   --------
          Net cash (used in) provided by financing
           activities.......................................     (710)    11,025
                                                              -------   --------
Net decrease in cash and cash equivalents...................     (952)   (30,014)
Cash and cash equivalents, beginning of period..............    1,670     31,133
                                                              -------   --------
Cash and cash equivalents, end of period....................  $   718   $  1,119
                                                              =======   ========
</TABLE>

     The accompanying notes are an integral part of the condensed financial
                                  statements.

                                        3
<PAGE>   6

                          HEALTHCARE RECOVERIES, INC.

                    NOTES TO CONDENSED FINANCIAL STATEMENTS
                                  (UNAUDITED)

1.  ORGANIZATION AND BASIS OF PRESENTATION

     Healthcare Recoveries, Inc. (hereinafter referred to as the "Company" or
"HCRI"), a Delaware corporation, was incorporated on June 30, 1988. The
Company's primary business is to provide complete outsourcing of insurance
subrogation and certain other medical claims recovery and cost containment
services to the private healthcare payor industry. Its primary service is
medical claims recovery, and its primary product is subrogation recovery, which
generally entails the identification, investigation and recovery of
accident-related medical benefits incurred by its clients on behalf of their
insureds, but for which other persons or entities have primary responsibility.
The Company's clients' rights to recover the value of these medical benefits,
arising by law or contract, are generally known as the right of subrogation and
are generally paid from the proceeds of liability or workers' compensation
insurance. The Company's other medical claims recovery services include hospital
bill auditing, contract compliance review and cost management consulting,
coordination of benefits and overpayments recovery services.

     The accompanying financial statements are presented in a condensed format
and consequently do not include all of the disclosures normally required by
generally accepted accounting principles or those normally made in the Company's
annual financial statements. Accordingly, for further information, the reader of
this Form 10-Q may wish to refer to the Company's audited financial statements
as of and for the year ended December 31, 1999, contained in the Company's
Annual Report on Form 10-K for the fiscal year ended December 31, 1999, filed
with the Securities and Exchange Commission on March 14, 2000.

     The financial information has been prepared in accordance with the
Company's customary accounting practices and has not been audited. In the
opinion of management, the information presented reflects all adjustments
necessary for a fair presentation of interim results. All such adjustments are
of a normal and recurring nature. Certain financial statement amounts have been
reclassified in the prior year to conform to the current period presentation.

2.  CONTINGENCIES

     The Company is engaged in the business of identifying and recovering
subrogation and related claims of its clients, many of which arise in the
context of personal injury lawsuits. As such, the Company operates in a
litigation-intensive environment. The Company has been, from time to time, and
in the future expects to be, named as a party in litigation incidental to its
business operations. To date, the Company has not been involved in any
litigation which has had a material adverse effect upon the Company, but there
can be no assurance that pending litigation or future litigation will not have a
material adverse effect on the Company's business, results of operations or
financial condition.

3.  CREDIT FACILITY

     On May 15, 2000, the Company entered into a third amendment (the
"Amendment") to its February 1, 1998 revolving credit facility with National
City Bank of Kentucky and the lenders named therein (the "Credit Facility"). The
Company's obligations under the Credit Facility are secured by substantially all
of the Company's assets, subject to certain permitted exceptions. Under the
Amendment, the maturity date was extended to April 30, 2002 from January 31,
2001, the maximum borrowing capacity decreased to $40 million from $50 million,
and certain other financial terms and covenants were amended. Principal amounts
outstanding under the Credit Facility bear interest at a variable rate based on
the Prime Rate or Eurodollar Rate, as applicable, plus the pre-determined fixed
margin. The Credit Facility contains customary covenants and events of default
including, but not limited to, financial tests for interest coverage, net worth
levels and leverage that may limit the Company's ability to pay dividends. It
also contains a material adverse change clause. The Company does not expect
changes in interest rates to have a material effect on its financial position,
results of operations or financial condition in 2000. The Credit Facility was
amended in May 1998 to
                                        4
<PAGE>   7
                          HEALTHCARE RECOVERIES, INC.

             NOTES TO CONDENSED FINANCIAL STATEMENTS -- (CONTINUED)

3.  CREDIT FACILITY -- (CONTINUED)
enable the Company to acquire entities that do not maintain audited financial
statements, in March 1999 to permit borrowings from the Credit Facility for
repurchasing up to $10 million of outstanding Common Stock, and in June 2000, to
increase the amount of other debt that the Company is permitted to maintain
outstanding under another of the Credit Facility's financial covenants. As of
September 30, 2000, $14.5 million was outstanding under the Credit Facility.

4.  STOCK REPURCHASE PLAN

     HCRI's Board approved a stock repurchase plan on March 12, 1999 under which
the Company is authorized to repurchase, from time to time, up to $10 million of
HCRI Common Stock in the open market, at prices per share deemed favorable by
the Company. Shares may be repurchased using cash from operations and borrowed
funds and may continue until such time as the Company has repurchased $10
million of HCRI Common Stock or until it otherwise determines to terminate the
stock repurchase plan. During 1999, HCRI acquired 305,000 shares of its Common
Stock at an average price of $4.50 per share. During the third quarter of 2000,
HCRI repurchased 520,000 shares of its Common Stock at an average price of $4.11
per share. The total number of shares repurchased during the first nine months
of 2000 is 1,028,185 with an average cost of $3.67 per share. Since inception of
the program and through September 30, 2000, the total number of repurchased
shares is 1,333,185, at a cost of $5.1 million, or $3.86 per share. Subsequent
to September 30, 2000, HCRI acquired an additional 162,580 shares of its Common
Stock at an average price of $4.37 per share. All of the reacquired shares of
Common Stock through September 30, 2000 are reflected as treasury stock on the
accompanying Condensed Balance Sheets (Unaudited).

5.  RELATED PARTY TRANSACTION

     On June 30, 2000, at the direction of the Board of Directors and in
accordance with terms authorized by it, the Company loaned to Patrick B.
McGinnis, the Chief Executive Officer of the Company, $500,000. Under these
terms, the $500,000 loan to Mr. McGinnis was combined with his existing debt to
the Company of $350,000 of principal and $36,520 of accrued interest. Mr.
McGinnis delivered to the Company his full recourse promissory note in the
amount of $886,520, bearing interest at a fixed rate of 6.62% per annum,
compounded annually (the "Amended Promissory Note"), and the Company cancelled
the old promissory note evidencing the prior debt. The Amended Promissory Note
provides for mandatory prepayments from certain of the proceeds received by Mr.
McGinnis from his sale of the Company's securities and any related transactions.
At September 30, 2000, the amount of accrued interest on the Amended Promissory
Note was $11,068.

     In addition, on June 30, 2000, pursuant to Board authorization and in
accordance with the terms of the Amended Promissory Note, the Company and Mr.
McGinnis entered into a deferred compensation agreement (the "Agreement"). Under
the Agreement, 50% of the amount otherwise payable to Mr. McGinnis under the
Company's Management Group Incentive Compensation Plan shall be deferred until
the Amended Promissory Note is paid in full, with such deferred compensation
then being paid in full to Mr. McGinnis within 30 days thereafter. The Company
has full right of set-off against any deferred compensation under the Agreement
should Mr. McGinnis default under the Amended Promissory Note. At the election
of Mr. McGinnis, the payment of the deferred compensation, upon payment of the
Amended Promissory Note, may be extended for a period of not more than ten
years.

                                        5
<PAGE>   8
                          HEALTHCARE RECOVERIES, INC.

             NOTES TO CONDENSED FINANCIAL STATEMENTS -- (CONTINUED)

6.  EARNINGS PER COMMON SHARE

     Reconciliations of the average number of common shares outstanding used in
the calculation of earnings per common share and earnings per common share
assuming dilution are as follows (dollars and shares in thousands, except per
share results):

<TABLE>
<CAPTION>
                                                    THREE MONTHS ENDED    NINE MONTHS ENDED
                                                       SEPTEMBER 30,        SEPTEMBER 30,
                                                    -------------------   -----------------
                                                      2000       1999      2000      1999
                                                    --------   --------   -------   -------
<S>                                                 <C>        <C>        <C>       <C>
Weighted average number of common shares
  outstanding.....................................   10,519     11,209     10,899    11,315
Add: Dilutive stock options.......................      123         --         65        49
                                                    -------    -------    -------   -------
Number of common shares outstanding (diluted).....   10,642     11,209     10,964    11,364
                                                    =======    =======    =======   =======
Net earnings for earnings per common share (basic
  and diluted)....................................  $ 1,245    $ 1,227    $ 3,667   $ 4,038
                                                    =======    =======    =======   =======
Earnings per common share:
  Basic...........................................  $  0.12    $  0.11    $  0.34   $  0.36
                                                    =======    =======    =======   =======
  Diluted.........................................  $  0.12    $  0.11    $  0.33   $  0.36
                                                    =======    =======    =======   =======
</TABLE>

     Basic earnings per common share were computed based on the weighted-average
number of shares outstanding during the period. The dilutive effect of stock
options was calculated using the treasury stock method. Options to purchase
1,545,294 and 1,586,127 shares for the three and nine month periods ended
September 30, 2000, respectively, and 1,547,869 and 1,148,430 shares for the
comparable periods in 1999, respectively, were not included in the computation
of diluted earnings per common share because the exercise prices of these
options were greater than the average market price of the common shares during
the respective periods.

7.  ACQUISITIONS

     On January 25, 1999, HCRI acquired the assets and certain liabilities of
Subro-Audit, Inc., a Wisconsin corporation ("SAI"), and a related entity,
O'Donnell Leasing Co., LLP, a Wisconsin limited liability partnership ("ODL"
and, together with SAI, the "Subro Audit Acquisition"), for approximately $24.4
million, using available unrestricted cash. HCRI estimates that it may pay up to
$7.0 million through January 2001, pursuant to an earn-out arrangement, of which
$2.8 million was paid on May 18, 2000. Approximately $4.9 and $8.5 million was
held in escrow for the potential earn-out and was included in restricted cash at
September 30, 2000 and December 31, 1999, respectively. SAI is based in
Wisconsin and provides subrogation recovery services with respect to an
installed base of lives, which are covered by insurers, HMOs and employer-funded
plans, throughout the United States. The Subro Audit Acquisition was accounted
for using the purchase method of accounting.

     On February 15, 1999, HCRI acquired the assets and certain liabilities of
MedCap Medical Cost Management, Inc., a California corporation ("MedCap"), for
approximately $10 million, using available unrestricted cash and borrowed funds
(the "MedCap Acquisition" and, together with the Subro Audit Acquisition, the
"Acquisitions"). HCRI paid approximately $4.5 million on February 15, 2000
pursuant to an amendment to the original earn-out agreement. Pursuant to the
same amendment, through January 15, 2001, HCRI may pay up to 50% of the fees
collected in relation to certain negotiated contracts, less associated expenses,
as an additional earnout. To date, the amount paid in relation to the fees
collected on those contracts approximates $282,000. MedCap provides a variety of
medical cost management services to health insurers and HMOs, primarily in
California. These services include hospital bill auditing, contract compliance
review,

                                        6
<PAGE>   9
                          HEALTHCARE RECOVERIES, INC.

             NOTES TO CONDENSED FINANCIAL STATEMENTS -- (CONTINUED)

7.  ACQUISITIONS -- (CONTINUED)
identification of certain other payments, and cost management consulting
services. The MedCap Acquisition was accounted for using the purchase method of
accounting.

     If the Acquisitions had taken place on January 1, 1999, approximate claims
revenues, net income and earnings per diluted share for the nine months ended
September 30, 1999 would have been $46.4 million, $4.0 million and $0.35,
respectively. The cost in excess of net tangible and identifiable intangible
assets acquired, allocated and recorded in connection with the Acquisitions was
approximately $30.8 million and is being amortized over an 18 to 20-year period.
These results may not necessarily reflect future results of operations or what
the results of operations would have been had the Acquisitions actually been
consummated at the beginning of 1999.

                                        7
<PAGE>   10

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

OVERVIEW OF COMPANY

     The Company's primary business is to provide medical claims recovery and
cost containment services to the private healthcare payor industry. Its primary
service is subrogation recovery, which generally entails the complete
outsourcing of the identification, investigation and recovery of
accident-related medical benefits incurred by its clients on behalf of their
insureds, but for which other persons or entities have primary responsibility.
The rights of HCRI's clients to recover the value of these medical benefits,
arising by law or contract, are known generally as the right of subrogation and
are generally paid from the proceeds of liability or workers' compensation
insurance. The Company's other medical cost containment services include
hospital bill auditing, contract compliance review, cost management consulting,
coordination of benefits and overpayment recovery services. HCRI offers its
services on a nationwide basis to health maintenance organizations, indemnity
health insurers, self-funded employee health plans, and companies that provide
claims administration services to self-funded plans (referred to as "third-party
administrators"). The Company had 53.2 million lives under contract from its
clientele at September 30, 2000.

ACQUISITIONS

     On January 25, 1999, HCRI acquired the assets and certain liabilities of
Subro-Audit (which consisted of SAI and ODL), for approximately $24.4 million,
using available unrestricted cash. HCRI estimates that it may pay up to $7.0
million through January 2001, pursuant to an earn-out arrangement, of which $2.8
million was paid on May 18, 2000. Approximately $4.9 and $8.5 million was held
in escrow for the potential earn-out and was included in restricted cash at
September 30, 2000 and December 31, 1999, respectively. SAI is based in
Wisconsin and provides subrogation recovery services with respect to an
installed base of lives, which are covered by insurers, HMOs and employer-funded
plans, throughout the United States. The Subro Audit Acquisition was accounted
for using the purchase method of accounting.

     On February 15, 1999, HCRI acquired the assets and certain liabilities of
MedCap for approximately $10 million, using available unrestricted cash and
borrowed funds. The Company paid approximately $4.5 million on February 15, 2000
pursuant to an amendment to the original earn-out agreement. Pursuant to the
same amendment, through January 15, 2001, HCRI may pay up to 50% of the fees
collected in relation to certain negotiated contracts, less associated expenses,
as an additional earnout. To date, the amount paid in relation to the fees
collected on those contracts approximates $282,000. MedCap provides a variety of
medical cost management services to health insurers and HMOs, primarily in
California. These services include hospital bill auditing, contract compliance
review, identification of certain other payments, and cost management consulting
services. The MedCap Acquisition was accounted for using the purchase method of
accounting.

OVERVIEW OF OPERATIONS

     For a typical new client, it takes up to six months from the contract
signing (when the lives are "sold") to complete the construction of electronic
data interfaces necessary for the Company to begin providing service. At this
point, the client is considered "installed". During the installation period, the
Company must also hire and train quality staff necessary to provide contractual
services. After installation, HCRI receives files and data from the client from
which it creates an inventory of backlog.

     "Backlog" is the total dollar amount of potentially recoverable claims that
the Company is pursuing or auditing on behalf of its clients at a given point in
time. These claims are gross figures, prior to estimates of claim settlements
and rejections. Backlog increases when the Company opens new files of
potentially recoverable claims and decreases when files are recovered and closed
or, after further investigation, determined to be nonrecoverable. Backlog for a
client will range from newly identified potential recoveries to potential
recoveries that are in the late stages of the recovery process. Historically,
recoveries (the amount actually recovered for the Company's clients prior to the
Company's fee) have been produced from backlog in a generally predictable cycle.
Any group of potential recoveries, sufficiently large in number to display
statistically significant characteristics and that originates from a defined
time period, tends to produce recovery results that are comparable to other
groups having similar characteristics.

                                        8
<PAGE>   11

OVERVIEW OF OPERATIONS -- (CONTINUED)
     For the most part, the Company is paid contingency fees from the amount of
claims recoveries it makes from backlog or recoveries it identifies through
other cost containment and related recovery services on behalf of its clients.
The Company's revenues are a function of recoveries and effective fee rates.
Effective fee rates vary depending on the mix between services provided and
client fee schedules. The fee schedules for each client are separately
negotiated and reflect the Company's standard fee rates, the services to be
provided and the anticipated volume of services. The Company grants volume
discounts and, for its recovery services, negotiates a lower fee when it assumes
backlog from a client because the client will have already completed some of the
recovery work. Because the Company records expenses as costs are incurred and
records revenues only when a file is settled, there is a lag between the
recording of expenses and related revenue recognition.

     The Company's expenses are determined primarily by the number of employees
directly engaged in recovery activities ("cost of services") and by the number
of employees engaged in a variety of support activities ("support expenses").
Recovery personnel must be hired and trained in advance of the realization of
recoveries and revenues. Historically, support expenses have not grown in direct
proportion to revenues.

RESULTS OF OPERATIONS

     The following tables present certain key operating indicators and results
of operations data for the Company for the periods indicated:

                            KEY OPERATING INDICATORS
              (IN MILLIONS, EXCEPT FOR PERCENTAGES AND EMPLOYEES)

<TABLE>
<CAPTION>
                                         THREE MONTHS ENDED         NINE MONTHS ENDED
                                           SEPTEMBER 30,              SEPTEMBER 30,
                                       ----------------------     ----------------------
                                         2000          1999         2000          1999
                                       --------      --------     --------      --------
<S>                                    <C>           <C>          <C>           <C>
Cumulative lives sold, beginning of
  period.............................      53.6          59.3         55.6          40.5
  Lives from acquisitions............        --            --           --          18.6
  Lives from existing client loss,
     net.............................      (1.8)         (3.6)        (4.6)         (5.4)
  Lives added from new contracts with
     existing clients................       0.8           0.4          0.8           0.6
  Lives added from contracts with new
     clients.........................       0.6           0.3          1.4           2.1
                                       --------      --------     --------      --------
Cumulative lives sold, end of
  period.............................      53.2          56.4         53.2          56.4
                                       ========      ========     ========      ========
Lives installed......................      50.1          50.5         50.1          50.5
Backlog(1)...........................  $1,214.6      $1,078.6     $1,214.6      $1,078.6
Claims recoveries....................  $   56.8      $   56.3     $  177.5      $  165.3
Throughput(2)........................       4.8%          5.3%        15.4%         15.2%
Effective fee rate...................      26.6%         27.1%        26.8%         27.2%
Employees
  Direct operations..................       526           553          526           553
  Support............................       154           146          154           146
                                       --------      --------     --------      --------
          Total employees............       680           699          680           699
                                       ========      ========     ========      ========
</TABLE>

---------------

(1) Backlog is the total dollar amount of potentially recoverable claims that
    the Company is pursuing or auditing on behalf of its clients at a given
    point in time.
(2) Throughput equals claims recoveries for the period divided by the average of
    backlog at the beginning and end of the period.

                                        9
<PAGE>   12

RESULTS OF OPERATIONS -- (CONTINUED)
                STATEMENTS OF INCOME AS A PERCENTAGE OF REVENUES

<TABLE>
<CAPTION>
                                                            THREE MONTHS         NINE MONTHS
                                                                ENDED               ENDED
                                                            SEPTEMBER 30,       SEPTEMBER 30,
                                                           ---------------     ---------------
                                                           2000      1999      2000      1999
                                                           -----     -----     -----     -----
<S>                                                        <C>       <C>       <C>       <C>
Claims revenues..........................................  100.0%    100.0%    100.0%    100.0%
Cost of services.........................................   48.4      52.4      49.2      51.2
Support and Special Committee expenses...................   26.1      25.3      27.3      25.7
Depreciation and amortization............................   10.8       8.6      10.0       8.0
Operating income.........................................   14.6      13.7      13.7      15.1
Income before income taxes...............................   14.1      13.8      13.2      15.4
Net income...............................................    8.2       8.0       7.7       9.0
</TABLE>

  Three and nine months ended September 30, 2000 compared to three and nine
  months ended September 30, 1999

     Claims Revenues.  Although claims recoveries increased 1%, to $56.8 million
in the quarter ended September 30, 2000 from $56.3 million in the same quarter
of 1999, claims revenues for the current quarter decreased less than 1% to $15.1
million, from $15.2 million in the third quarter of 1999, primarily because the
effective fee rate for the quarter ended September 30, 2000 decreased to 26.6%
from 27.1% in the same quarter of 1999. The effective fee rate in the quarter
fell because of the recovery mix in the quarter, with relatively more recoveries
coming from clients with a lower fee rate.

     The 1% increase in recoveries in the quarter ended September 30, 2000 over
the comparable quarter of 1999 resulted primarily from the increase in backlog,
which grew 12.6% over the same period. However, recoveries over this period grew
more slowly than did backlog primarily because of the timing of the backlog
growth, most of which was added recently, and so was not mature enough to become
productive within the quarter. In addition, recovery results were adversely
affected by lower than historical levels of production from a particular
subrogation unit that specializes in large files. The Company expects this unit
to return to historically normal productivity levels by the end of 2000 as a
result of changes to operating processes. Throughput fell from 5.3% to 4.8% as a
result of the growth in backlog without a corresponding increase in recoveries,
as discussed above, and as a result of the productivity issue mentioned above.

     Comparing the nine month period ended September 30, 2000 with that ended
September 30, 1999, revenues increased 6% on a 7% increase in recoveries.
Revenues increased slightly slower than did recoveries because the effective fee
rate declined to 26.8% from 27.2% as a result of a change in the recovery mix,
with relatively more recoveries coming from clients with lower fee rates.

     The 7% increase in recoveries in the nine month period ended September 30,
2000 over the comparable period of 1999 resulted primarily from the increase in
backlog discussed above and as an effect of the Acquisitions. Because both
Acquisitions were closed within the first quarter of 1999, a full three quarters
of activity related to the Acquisitions is reported in the results for the first
nine months of 2000, while slightly less than three full quarters of activity
was included in the results for the first nine months of 1999. This reporting
anomaly caused an increase in the recovery growth rate from the 1999 period to
the 2000 period. Improved productivity in areas of the Company's operations
other than the large subrogation file unit resulted in an improvement in
throughput from 15.2% for the nine month period ended September 30, 1999 to
15.4% for the comparable nine month period in 2000. Although installed lives
decreased from 50.5 million at September 30, 1999 to 50.1 million at September
30, 2000, backlog increased $136 million from $1,078.6 million to $1,214.6
million, respectively. The reason that backlog increased during the same period
in which lives installed decreased is that the Company typically continues to
make recoveries on the backlog of terminated clients that exists as of the
contract termination date, until that backlog is exhausted (i.e., usually 5 to 6
years), but removes terminated clients from the category of "lives installed" as
of the contract termination date.

                                       10
<PAGE>   13

RESULTS OF OPERATIONS -- (CONTINUED)
     Cost of Services.  Cost of services decreased 9% for quarter ended
September 30, 2000 to $7.3 million, from $8.0 million for the comparable period
in 1999 and was $23.4 million for the nine months ended September 30, 2000, an
increase of 2% from $23.0 million for the same period in 1999. The increase for
the nine month period is attributable to the inclusion of a full nine months of
cost of services for the Acquisitions in the 2000 period. As a percentage of
claims revenues, cost of services decreased to 48.4% for the quarter ended
September 30, 2000 compared to 52.4% for the prior year quarter. For the nine
months ended September 30, 2000, cost of services as a percentage of claims
revenues decreased to 49.2% from 51.2% in the comparable 1999 period. The
decrease in cost of services as a percentage of claims revenues for the
comparable quarters and nine month periods resulted from a reduction in cost of
services, due to certain productivity enhancements instituted earlier in the
year.

     Support Expenses.  Support expenses increased 3% to $4.0 million for the
quarter ended September 30, 2000 from $3.9 million for the comparable quarter in
1999 and was $12.9 million for the nine month period ended September 30, 2000,
an increase of 12% from $11.5 million for the same period in 1999. The increases
were due to hiring additional staff to support the planned growth and
development of new operations. Support expenses increased as a percentage of
claims revenues from 25.7% for the nine month period ended September 30, 1999 to
27.3% for the same period in 2000. The increase in support expenses as a
percentage of claims revenues resulted primarily from expenses incurred in the
development of new operations. Support expenses typically do not vary in
proportion to revenues.

     Depreciation and Amortization.  Depreciation and amortization expenses
increased 23% to $1.6 million for the quarter ended September 30, 2000 from $1.3
million for the same period in 1999, and increased 33% to $4.8 million for the
nine months ended September 30, 2000 from $3.6 million for the comparable period
in 1999. The increase in depreciation expense was attributable to the purchased
property and equipment related to the Acquisitions and system upgrades. The
increase in amortization expense was attributable to the addition of intangible
assets acquired in the Acquisitions.

     Interest Expense.  Interest expense totaled $375,000 and $263,000 for the
quarter ended September 30, 2000 and 1999, respectively, and $1,004,000 and
$681,000 for the nine months ended September 30, 2000 and 1999, respectively.
The increase in interest expense for the quarter and nine months ended September
30, 2000, as compared with the respective periods in 1999, is due to an increase
in borrowed funds relating to the stock repurchase program and the MedCap
earnout payment, and due to higher effective interest rates during 2000.

     Other -- Special Committee Expenses.  In August 1999, HCRI's Board of
Directors appointed a Special Committee to evaluate strategic alternatives
available to the Company, including its possible sale. During the first quarter
of 2000, the Company incurred $90,000 of expenses related to the work of the
committee. In March 2000, the Special Committee ceased seeking a buyer for the
Company and its efforts to enhance shareholder value were assumed by the full
Board of Directors.

     Tax.  Provision for income taxes was approximately 41.5% of pre-tax income
for the three and nine months ended September 30, 2000 and 1999. The effective
tax rate exceeded the Federal statutory tax rate as a consequence of state and
local taxes and non-deductible expenses.

     Net Income.  Net income for the quarter ended September 30, 2000 increased
slightly to $1.25 million or $0.12 per diluted share from $1.23 million or $0.11
per diluted share for the comparable period in 1999. For the nine months ended
September 30, 2000, net income decreased $0.3 million, or 8%, to $3.7 million,
or $0.33 per diluted share, from $4.0 million, or $0.36 per diluted share for
the comparable period in 1999. The primary factors offsetting the increase in
claims revenues between the comparable nine month periods, and contributing to
the decline in net income for the nine months ended September 30, 2000, were
support, interest and amortization expenses related to the Acquisitions.
Although net income per diluted share declined between the comparable nine month
periods, earnings per diluted share increased in the quarter ended September 30,
2000 compared to the quarter ended September 30, 1999, primarily as a result of
the stock repurchase program. (See Note 4 -- Stock Repurchase Program.)

                                       11
<PAGE>   14

LIQUIDITY AND CAPITAL RESOURCES

     The Company's statements of cash flows for the nine months ended September
30, 2000 and 1999 are summarized below (in thousands):

<TABLE>
<CAPTION>
                                                               NINE MONTHS ENDED
                                                                 SEPTEMBER 30,
                                                              -------------------
                                                               2000        1999
                                                              -------    --------
                                                                (IN THOUSANDS)
<S>                                                           <C>        <C>
Net cash provided by operating activities...................  $ 4,736    $  6,620
Net cash used in investing activities.......................   (4,978)    (47,659)
Net cash (used in) provided by financing activities.........     (710)     11,025
                                                              -------    --------
Net decrease in cash and cash equivalents...................  $  (952)   $(30,014)
                                                              =======    ========
</TABLE>

     The Company had working capital of $10.6 million at September 30, 2000,
including cash and cash equivalents of $0.7 million, compared with working
capital of $7.9 million at December 31, 1999. The primary reason for the
increase was the increase in accounts receivable and timing of payments of
accrued expenses.

     Net cash provided by operating activities was $4.7 million, a decrease of
$1.9 million for the nine months ended September 30, 2000, compared to the same
period in 1999, primarily as a result of the timing of recurring cash receipts
and disbursements related to accounts receivables and accrued expenses.

     Net cash used in investing activities includes $4.8 million paid under the
earnout agreements related to the Acquisitions. Capital expenditures for the
nine months ended September 30, 2000 were approximately $2.5 million. Disposals
of property and equipment of $1.4 million included the sale of a building owned
in Atlanta, Georgia. Excluding any future acquisitions, the Company anticipates
capital expenditures for the year to be approximately $3.6 million, which
reflects a lower estimate for the current year than previously disclosed.

     Net cash used in financing activities for the nine months ended September
30, 2000 reflects $3.5 million in net cash borrowings from the Company's credit
facility, as discussed below.

     On May 15, 2000, the Company entered into a third amendment (the
"Amendment") to its February 1, 1998 revolving credit facility with National
City Bank of Kentucky and the lenders named therein (the "Credit Facility"). The
Company's obligations under the Credit Facility are secured by substantially all
of the Company's assets, subject to certain permitted exceptions. Under the
Amendment, the maturity date was extended to April 30, 2002 from January 31,
2001, the maximum borrowing capacity decreased to $40 million from $50 million,
and certain other financial terms and covenants were amended. Principal amounts
outstanding under the Credit Facility bear interest at a variable rate based on
the Prime Rate or Eurodollar Rate, as applicable, plus the pre-determined fixed
margin. The Credit Facility contains customary covenants and events of default
including, but not limited to, financial tests for interest coverage, net worth
levels and leverage that may limit the Company's ability to pay dividends. It
also contains a material adverse change clause. The Company does not expect
changes in interest rates to have a material effect on its financial position,
results of operations or financial condition in 2000. The Credit Facility was
amended in May 1998 to enable the Company to acquire entities that do not
maintain audited financial statements, in March 1999 to permit borrowings from
the Credit Facility for repurchasing up to $10 million of outstanding Common
Stock, and in June 2000, to increase the amount of other debt that the Company
is permitted to maintain outstanding under another of the Credit Facility's
financial covenants. As of September 30, 2000, $14.5 million was outstanding
under the Credit Facility.

     At September 30, 2000 and December 31, 1999, the Company reported on its
balance sheets, as a current asset, restricted cash of $19.9 million and $26.1
million, respectively. Restricted cash at September 30, 2000 and December 31,
1999 represented claims recoveries effected by HCRI for its clients and also
included an escrowed amount of $4.9 million and $8.5 million, respectively, for
a potential earn-out in connection with the Subro-Audit Acquisition. At
September 30, 2000 and December 31, 1999, HCRI reported on its balance sheets,
as a current liability, funds due clients of $11.4 million and $13.2 million,
respectively, representing claims recoveries to be distributed to clients, net
of the fee earned on such recoveries.

                                       12
<PAGE>   15

LIQUIDITY AND CAPITAL RESOURCES -- (CONTINUED)
     The Company believes that its available cash resources, together with the
borrowings available under the Credit Facility, will be sufficient to meet its
2000 operating requirements and internal development initiatives.

EXTERNAL FACTORS

     The business of recovering subrogation and other claims for healthcare
payors is subject to a wide variety of external factors. Prominent among these
are factors that would materially change the healthcare payment, fault-based
liability or workers' compensation systems. Examples of these factors include,
but are not limited to, 1) the non-availability of recovery from such sources as
property and casualty and workers' compensation coverages, 2) law changes that
limit the use of or access to claims and medical records, or 3) the ability of
healthcare payors to recover related claims and audit medical records. Because
the Company's profitability depends in large measure upon obtaining and using
claims data and medical records, the non-availability or decrease in their
availability could have a material adverse effect on the Company.

     Moreover, because the Company's revenues are derived from the recovery of
the costs of medical treatment, material changes in such costs will tend to
affect the Company's backlog or its rate of backlog growth, as well as its
revenue or its rate of revenue growth. The healthcare industry, and particularly
the business of healthcare payors, is subject to various external factors that
may have the effect of significantly altering the costs of healthcare and the
environment for the sale or delivery of medical claims recovery and cost
containment services. The Company is unable to predict which of these factors,
if any, could have a potentially material impact on healthcare payors and
through them, the healthcare recovery and cost containment industry.

CONCENTRATION OF CLIENTS

     The Company provides services to healthcare plans that as of September 30,
2000 covered approximately 53.2 million lives. HCRI's clients are national and
regional healthcare payors, large third-party administrators or self-insured
corporations. For the nine month periods ended September 30, 2000 and 1999,
HCRI's largest client, UnitedHealth Group, generated 24% and 23%, respectively,
of HCRI's revenues. The loss of this account could have a material adverse
effect on the Company's business, results of operations and financial condition.
On September 30, 2000, HCRI had backlog of $1,214.6 million. Claims revenues are
earned under written contracts with HCRI's clients that generally provide for
contingency fees from recoveries under a variety of pricing regimes. The pricing
arrangements offered by HCRI to its clients include a fixed fee percentage, a
fee percentage that declines as the number of lives covered by the client and
subject to HCRI's service increases and a fee percentage that varies with HCRI's
recovery performance.

     HCRI does not obligate itself to deliver any specific result from the
performance of its services. Contracts with its customers are generally
terminable on 60 to 180 days' notice by either party, although several contracts
extend over a period of years. Pursuant to the terms of its client contracts,
HCRI is generally entitled to continue to make recoveries for the client and
earn a fee on the backlog existing at the time of termination.

RECENT DEVELOPMENTS

  Resignation of a Director

     Effective October 31, 2000, Elaine J. Robinson resigned as a director of
the Company. Under the Company's Certificate of Incorporation, a vacancy on the
Board of Directors created by a resignation may be filled by a majority vote of
the remaining directors. A director so chosen to fill the vacancy will hold
office until the next Annual Meeting (i.e. in 2001). The Board of Directors,
through its Nominating Committee, is currently engaged in identifying candidates
for the vacant position.

  New Client Contracts

     During the quarter ended September 30, 2000, the Company signed a material
contract with a leading provider of enrollment, billing and collection, claims
administration, and risk management services, under

                                       13
<PAGE>   16

RECENT DEVELOPMENTS -- (CONTINUED)
which HCRI will sell its subrogation services and hospital bill audit and
overpayment products to that service provider's customers, with the service
provider acting as the vehicle for client enrollment. HCRI estimates that this
service provider's customers cover or insure approximately 950,000 lives. None
of these customers have, as yet, enrolled for HCRI services.

  Stock Repurchase Plan

     HCRI's Board approved a stock repurchase plan on March 12, 1999 under which
the Company is authorized to repurchase, from time to time, up to $10 million of
HCRI Common Stock in the open market, at prices per share deemed favorable by
the Company. Shares may be repurchased using cash from operations and borrowed
funds and may continue until such time as the Company has repurchased $10
million of HCRI Common Stock or until it otherwise determines to terminate the
stock repurchase plan. During 1999, HCRI acquired 305,000 shares of its Common
Stock at an average price of $4.50 per share. During the third quarter of 2000,
HCRI repurchased 520,000 shares of its Common Stock at an average price of $4.11
per share. The total number of shares repurchased during the first nine months
of 2000 is 1,028,185 with an average cost of $3.67 per share. Since inception of
the program and through September 30, 2000, the total number of repurchased
shares is 1,333,185, at a cost of $5.1 million, or $3.86 per share. Subsequent
to September 30, 2000, HCRI acquired an additional 162,580 shares of its Common
Stock at an average price of $4.37 per share. All of the reacquired shares of
Common Stock through September 30, 2000 are reflected as treasury stock on the
accompanying Condensed Balance Sheets (Unaudited).

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     An element of market risk exists for the Company from changes in interest
rates related to its amended Credit Facility, which matures April 30, 2002. The
impact on earnings and value of any debt on the Company's balance sheets are
subject to change as a result of movements in market rates and prices as the
Credit Facility is subject to variable interest rates. However, the Company does
not expect changes in interest rates to have a material effect on its financial
position, results of operations or cash flows in 2000. As of September 30, 2000,
the Company had $14.5 million outstanding under its Credit Facility, with
interest rates ranging from 8.8% to 10.0%. See "Management's Discussion and
Analysis of Financial Condition and Results of Operations -- Liquidity and
Capital Resources".

                                       14
<PAGE>   17

                                    PART II

                               OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

     On March 15, 1994, a class action complaint ("Complaint") was filed against
HCRI in the United States District Court for the Northern District of West
Virginia, Michael L. DeGarmo, et al. v. Healthcare Recoveries, Inc. The
plaintiffs assert that HCRI's subrogation recovery efforts on behalf of its
clients violate a number of state and federal laws, including the Fair Debt
Collection Practices Act and the Racketeering Influenced and Corrupt
Organizations Act ("RICO"). The Complaint alleges that HCRI engaged in
fraudulent or negligent practices on behalf of its clients by attempting to
recover, via subrogation, amounts in excess of the actual amounts paid for those
services and that HCRI pursued subrogation recoveries from individuals whose
health insurance plans did not specifically provide for subrogation. HCRI has
responded to these allegations by maintaining that the subrogation rights of its
clients provide for recovery of medical treatment at the "prevailing rates" or
"reasonable value" of those services and that instances in which recoveries were
made or sought against individuals without specific plan language occurred due
to either mistaken referrals from clients or reliance on equitable or common law
subrogation rights. On March 30, 1999, the court entered an order certifying a
class of all members of one HCRI client health plan located in Wheeling, West
Virginia (The Health Plan of the Upper Ohio Valley) who have been subject to
subrogation and/or reimbursement collection practices by HCRI. Plaintiffs, on
behalf of the class as certified, demand compensatory damages, punitive damages,
and treble damages under RICO, costs and reasonable attorneys' fees. The court
has ordered that all dispositive motions in the case be filed by late November
2000. Trial is scheduled to begin in March 2001.

     On October 1, 1999, a First Amended Class Action Complaint ("Amended
Complaint") was filed against HCRI in the United States District Court for the
Southern District of Florida, in a putative class action brought by William
Conte and Aaron Gideon, individually and on behalf of all others similarly
situated. In that action, Conte v. Healthcare Recoveries, Inc., No. 99-10062,
plaintiffs assert that HCRI's subrogation recovery efforts on behalf of its
clients violate a number of state and federal laws, including the Fair Debt
Collection Practices Act and the Florida Consumer Collection Practices Act. The
Complaint also seeks a declaratory judgment that HCRI, as the subrogation agent
for various healthcare payors, is not entitled to assert and recover upon
subrogation or reimbursement liens it asserts on settlements obtained from third
party tortfeasors when the settlement is in an amount less than the amount
required to fully compensate (or "make whole") the injured party for all
elements of damage caused by the tortfeasor. Plaintiffs purport to represent a
class consisting of all participants or beneficiaries of ERISA plans nationwide
whose net recovery of damages through judgments, settlements or otherwise
against liable third parties has been reduced or potentially reduced by HCRI's
alleged assertion and/or recovery of unlawful subrogation/reimbursement rights
of its clients. Plaintiffs also seek compensatory and statutory damages,
exemplary and punitive damages, injunctive relief, prejudgment interest, costs
and attorneys' fees.

     The original complaint in the Conte matter, filed in June 1999, asserted
similar claims on behalf of a putative class of participants or beneficiaries of
one client's health plans located in Florida, Alabama, and Georgia. In response
to HCRI's motion to dismiss that complaint, the plaintiffs filed the Amended
Complaint on behalf of a putative national class. On November 5, 1999, HCRI
filed a motion to dismiss the Amended Complaint. That motion, now fully briefed,
remains pending. The court has not yet addressed the question of whether to
certify the putative class. That motion has also been fully briefed and remains
pending.

     On October 20, 1999, a class action complaint ("Baker Complaint") was filed
against HCRI and one HCRI client in the Circuit Court of Jefferson County
Alabama, Darrell DeWayne Baker v. Healthcare Recoveries, Inc., United Healthcare
of Alabama, and Fictitious Party Defendants A, B, C et al. On December 6, 1999,
the defendants removed the lawsuit to the United States District Court for the
Northern District of Alabama, Southern Division. On January 3, 2000, a First
Amended Complaint was filed, retaining all counts from the original complaint
and seeking an additional declaratory judgment that the health plan and HCRI
have a right to recover through subrogation only the actual benefits paid to
medical providers on behalf

                                       15
<PAGE>   18

of the class. The Baker Complaint, as amended, asserts claims on behalf of two
putative subclasses, both consisting of members nationwide of the client health
plan, who either: (1) allegedly paid inflated subrogation claims due to alleged
failure by the health plan or by HCRI to disclose discounts in the health plan's
payments to medical providers; or (2) allegedly were denied coverage of certain
claims by the health plan. The plaintiffs assert claims against HCRI under a
variety of theories including unjust enrichment, breach of contract, breach of
fiduciary duty and violations of RICO. Plaintiffs demand, on behalf of the
putative classes, compensatory damages, punitive damages, treble damages under
RICO, and reasonable attorneys' fees. On January 27, 2000, the defendants filed
a motion to dismiss the Amended Complaint, which remains pending. The court has
not yet addressed the question of whether to certify the putative class.

     On October 28, 1999, a class action Plaintiff's Original Petition
("Petition") was filed against HCRI and one HCRI client in the District Court
for the 150th Judicial District, Bexar County, Texas, Joseph R. Cajas, on behalf
of himself and all others similarly situated v. Prudential Health Care Plan,
Inc. and Healthcare Recoveries, Inc. The plaintiff asserts that HCRI's
subrogation recovery efforts on behalf of its client Prudential Health Care
Plan, Inc. ("Prudential") violated a number of common law duties, as well as the
Texas Insurance Code and the Texas Business and Commerce Code. The Petition
alleges that HCRI, as the subrogation agent for Prudential, made fraudulent
misrepresentations in the course of unlawfully pursuing subrogation and
reimbursement claims that plaintiffs assert are unenforceable because (1)
prepaid medical service plans may not exercise rights of subrogation and
reimbursement; (2) the subrogation and reimbursement claims asserted by the
Company are not supported by contract documents that provide enforceable
recovery rights and/or do not adequately describe the recovery rights; and (3)
the sums recovered pursuant to such claims unlawfully exceed the amount
Prudential paid for medical goods and services. HCRI was served with the
Petition in early November 1999, and has answered, denying all allegations. The
court has not yet addressed the question of whether to certify the putative
class.

     In late 1999, the Cajas plaintiff's counsel filed two lawsuits in Texas and
South Carolina that raise issues similar to those in the Cajas lawsuit. On
December 7, 1999, a class action complaint ("Complaint") was filed against HCRI
and one HCRI client in the United States District Court for the Western District
of Texas, San Antonio Division, Timothy Patrick Franks, on behalf of himself and
similarly situated persons v. Prudential Health Care Plan, Inc. and Healthcare
Recoveries, Inc. The plaintiff asserts claims on behalf of members of ERISA
governed health plans. The Complaint alleges that HCRI's subrogation recovery
efforts on behalf of its client Prudential violated a number of common law
duties, as well as the terms of certain ERISA plan documents, RICO, the federal
Fair Debt Collection Practices Act, the Texas Insurance Code and the Texas
Business and Commerce Code. The Complaint alleges that HCRI, as the subrogation
agent for Prudential, made fraudulent misrepresentations in the course of
unlawfully pursuing subrogation and reimbursement claims that plaintiffs assert
are unenforceable because (1) prepaid medical service plans may not exercise
rights of subrogation and reimbursement; (2) the subrogation and reimbursement
claims asserted by the Company are not supported by contract documents that
provide enforceable recovery rights and/or do not adequately describe the
recovery rights; and (3) the sums recovered pursuant to such claims unlawfully
exceed the amount Prudential paid for medical goods and services. The Complaint
further alleges that HCRI unlawfully pursued subrogation and reimbursement
claims by (1) failing to pay pro rata attorney's fees to attorneys who
represented class members with respect to tort claims underlying the subrogation
and reimbursement claims; and (2) recovering subrogation and reimbursement
claims from class members who have not been fully compensated for their
injuries. Plaintiffs, on behalf of the class, demand compensatory damages,
punitive damages, and treble damages under RICO, costs and reasonable attorneys'
fees. In April 2000, the court permitted Franks to amend the Complaint (the
"Amended Complaint"), thus rendering moot a motion to dismiss which had been
filed by HCRI and Prudential. On May 2, 2000, HCRI and Prudential filed a motion
to dismiss the Amended Complaint. The motion to dismiss the Amended Complaint is
now pending before the court. The court has not yet addressed the question of
whether to certify the putative class.

     On December 22, 1999, a class action Complaint was filed against HCRI and
one HCRI client in the Court of Common Pleas of Richland County, South Carolina,
Estalita Martin et al. vs. Companion Health Care Corp., and Healthcare
Recoveries, Inc. On January 21, 2000, defendant Companion Healthcare Corp.
("CHC") filed an Answer and Counterclaim and plaintiff Martin filed a First
Amended Complaint

                                       16
<PAGE>   19

("Amended Complaint"). The Amended Complaint asserts that HCRI's subrogation
recovery efforts on behalf of its client CHC violated a number of common law
duties, as well as the South Carolina Unfair Trade Practices Act. The Amended
Complaint alleges that HCRI as the subrogation agent for CHC, made fraudulent
misrepresentations in the course of unlawfully pursuing subrogation and
reimbursement claims that plaintiffs assert are unenforceable because (1)
prepaid medical service plans may not exercise rights of subrogation and
reimbursement; (2) the subrogation and reimbursement claims asserted by the
Company are not supported by contract documents that provide enforceable
recovery rights and/or do not adequately describe the recovery rights; and (3)
the sums recovered pursuant to such claims unlawfully exceed the amount CHC was
entitled to collect for such medical goods and services. The Amended Complaint
further alleges that HCRI and CHC unlawfully pursued subrogation and
reimbursement claims by (1) failing to pay pro rata costs and attorney's fees to
attorneys who represented class members with respect to tort claims underlying
the subrogation and reimbursement claims; and (2) failing to include in
subrogation and reimbursement claims all applicable discounts that CHC received
for such medical goods and services. Plaintiffs, on behalf of the class, demand
compensatory damages, punitive damages, and treble damages, disgorgement of
unjust profits, costs, and prejudgment interest and attorneys' fees. HCRI was
served with the original Complaint in late December 1999 and has answered
denying all allegations. The court has not yet addressed the question of whether
to certify the putative class.

     The DeGarmo, Cajas, Franks, Baker and Martin lawsuits, or any one of them,
if successful, could prevent the Company from recovering the "reasonable value"
of medical treatment under discounted fee for service ("DFS"), capitation and
other payment arrangements. The DeGarmo, Conte, Cajas, Franks, Baker and Martin
lawsuits, or any one or more of them, if successful, could require the Company
to refund, on behalf of its clients, recoveries in a material number of cases.
In addition, an adverse outcome in any of the above referenced lawsuits could
impair materially HCRI's ability to assert subrogation or reimbursement claims
on behalf of its clients in the future.

     In terms of the Company's business practices and the allegations underlying
the DeGarmo, Cajas, Franks, Baker and Martin cases, at the end of 1993 HCRI had
ceased the practice of recovering the "reasonable value" of medical treatment
provided by medical providers under DFS arrangements with such clients. From
that date, the Company's policy has been not to recover the "reasonable value"
of medical treatment in DFS arrangements. However, HCRI historically and
currently recovers the "reasonable value" of medical treatment provided under
capitation arrangements and other payment arrangements with medical providers on
behalf of those clients that compensate medical providers under these payment
mechanisms, to the extent that these benefits are related to treatment of the
injuries as to which clients have recovery rights. The Company believes that its
clients' contracts, including the contracts that provide for recovery under DFS,
capitation and other payment arrangements are enforceable under the laws
potentially applicable in these cases. As a result, and taking into account the
underlying facts in each of these cases, the Company believes it has meritorious
grounds to defend these lawsuits, it intends to defend the cases vigorously, and
it believes that the defense and ultimate resolution of the lawsuits should not
have a material adverse effect upon the business, results of operations or
financial condition of the Company. Nevertheless, if any of these lawsuits or
another lawsuit seeking relief under similar theories were to be successful, it
is likely that such resolution would have a material adverse effect on the
Company's business, results of operations and financial condition.

     Management of the Company has observed that, in parallel with
widely-reported legislative concerns with the healthcare payment system, there
also has occurred an increase in litigation, actual and threatened, including
class actions brought by nationally prominent attorneys, directed at healthcare
payors and related parties. As a result of the foregoing, there can be no
assurance that the Company will not be subject to further class action
litigation, that existing and/or future class action litigation against the
Company and its clients will not consume significant management time and/or
attention and that the cost of defending and resolving such litigation will not
be material.

                                       17
<PAGE>   20

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     (a) Exhibits

     The following list of Exhibits includes both exhibits submitted with this
Form 10-Q as filed with the Commission and those incorporated by reference to
other filings:

<TABLE>
<C>    <C>  <S>
 2.1    --  Asset Purchase Agreement, dated as of December 4, 1998, by
            and among the Registrant, MedCap Medical Cost Management,
            Inc. and Marcia Deutsch (incorporated by reference to
            Exhibit 2.1 of Registrant's Current Report on Form 8-K,
            Filed December 11, 1998, File No. 0-22585).
 2.2    --  Amendment to Asset Purchase Agreement, dated as of December
            8, 1999, by and among the Registrant, MedCap Medical Cost
            Management, Inc. and Marcia Deutsch (incorporated by
            reference to Exhibit 2.1 of Registrant's Current Report on
            Form 8-K, filed December 20, 1999, File No. 0-22585).
 2.3    --  Asset Purchase Agreement, dated as of January 3, 1999, by
            and among the Registrant, Subro-Audit, Inc., O'Donnell
            Leasing Co., LLP, Kevin O'Donnell and Leah Lampone
            (incorporated by reference to Exhibit 2.1 of Registrant's
            Current Report on Form 8-K, filed January 11, 1999, File No.
            0-22585).
 2.4    --  Amendment to Asset Purchase Agreement by and among the
            Registrant, Subro-Audit, Inc., O'Donnell Leasing Co., LLP,
            Kevin O'Donnell and Leah Lampone, dated as of January 25,
            1999 (incorporated by reference to Exhibit 2.2 of
            Registrant's Current Report on Form 8-K, filed February 3,
            1999, File No. 0-22585).
 3.1    --  Amended and Restated Certificate of Incorporation of the
            Registrant (incorporated by reference to Exhibit 3.1 of
            Registrant's Amendment No. 2 to Registration Statement on
            Form S-1, File No. 333-23287).
 3.2    --  Amended and Restated Bylaws of the Registrant (incorporated
            by reference to Exhibit 3.2 of Registrant's Amendment No. 2
            to Registration Statement on Form S-1, File No. 333-23287).
 4.1    --  Specimen Common Stock Certificate (incorporated by reference
            to Exhibit 4.1 of Registrant's Amendment No. 1 to
            Registration Statement on Form S-1, File No. 333-23287).
 4.2    --  Rights Agreement, dated February 12, 1999, between the
            Registrant and National City Bank of Kentucky, as Rights
            Agent, which includes as Exhibit A the Form of Certificate
            of Designations of the Preferred Stock, as Exhibit B the
            Form of Right Certificate and as Exhibit C the Summary of
            Rights to Purchase Preferred Stock (incorporated by
            Reference to Exhibit 4.1 of Registrant's Form 8-A, filed
            February 16, 1999, File No. 0-22585).
27.1    --  Financial Data Schedule (for SEC use only).
99.1    --  Healthcare Recoveries, Inc. Private Securities Litigation
            Reform Act of 1995 Safe Harbor Compliance Statement for
            Forward-Looking Statements (incorporated by reference to
            Exhibit 99.1 of Registrant's Annual Report on Form 10-K for
            the fiscal year ended December 31, 1999, filed March 14,
            2000, File No. 0-22585).
</TABLE>

     (b) Reports on Form 8-K

     The Company did not file any Current Reports on Form 8-K during the quarter
ended September 30, 2000.

                                       18
<PAGE>   21

                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                          HEALTHCARE RECOVERIES, INC.

  Date: November 13, 2000
                                                /s/ PATRICK B. MCGINNIS
                                          --------------------------------------
                                                   Patrick B. McGinnis
                                                 Chairman, President and
                                                 Chief Executive Officer

  Date: November 13, 2000                        /s/ DOUGLAS R. SHARPS
                                          --------------------------------------
                                                    Douglas R. Sharps
                                            Executive Vice President and Chief
                                                    Financial Officer
                                            Principal Financial and Accounting
                                                         Officer

                                       19